October 2025 Clinical Recap
October 2025 Clinical Recap Jake Goll, PharmD (jake.goll@theprismhealthgroup.com) serves as the clinical consultant at Prism Health Group, where he provides end-to-end oversight of clinical strategy through in-depth data analysis, proactive consultation, and subject matter expertise. GLP-1 Class Update: Rybelsus Gains Cardiovascular Indication Another GLP-1 has expanded its label. On October 17, 2025, Novo Nordisk […]